Drugs firm Pfizer’s own shares climbed 9% after it said that preliminary analysis
Drugs firm Pfizer’s own shares climbed 9% after it said that preliminary analysis
"The reports about Grok raise deeply troubling questions about how people's personal data has been used to generate intimate...
Read more